Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Ferrara

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Tuberculosis (Edinburgh, Scotland)|January 22, 2011
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and controlJustin O'Grady, Michael Hoelscher, Rifat Atun, et al.
Lung|September 20, 2024
Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung DiseasesUmberto Zanini, Jane Ding, Fabrizio Luppi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 11, 2024
Refining the definition of miliary/disseminated tuberculosis in CanadaYiming Huang, Richard Long, Giovanni Ferrara, et al.
Scientific Reports|June 11, 2024
Factors associated with phenotypes of dyspnea in post-COVID-19 condition: a cross-sectional studyMaeve P Smith, Heather Sharpe, Ronald W Damant, et al.
Frontiers in Medicine|March 2, 2026
Interstitial lung abnormalities: to treat or not to treat? The hamlet dilemmaUmberto Zanini, Giovanni Franco, Chiara Pirotta, et al.
Respiratory Medicine|February 14, 2006
Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugsLuigi Ruffo Codecasa, Giovanni Ferrara, Maurizio Ferrarese, et al.
The American Journal of Medicine|August 3, 2025
Decoding objective cough features in progressive pulmonary fibrosis: a 6-month feasibility studyMicheal D Feist, Yiming Huang, Meena Kalluri, et al.
BMJ Open Respiratory Research|September 2, 2024
Understanding facilitators and barriers to oxygen therapy for patients with interstitial lung diseaseHeather Sharpe, Samira D Rowland, Charlotte Pooler, et al.
Frontiers in Medicine|November 24, 2022
A case series of dermatomyositis following SARS-CoV-2 vaccinationAiriss R Chan, Jan Willem Cohen Tervaert, Desiree Redmond, et al.
The Lancet. Respiratory Medicine|February 8, 2014
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trialAliaksandr Skrahin, Raija K Ahmed, Giovanni Ferrara, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Tuberculosis (Edinburgh, Scotland)|January 22, 2011
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and controlJustin O'Grady, Michael Hoelscher, Rifat Atun, et al.
Lung|September 20, 2024
Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung DiseasesUmberto Zanini, Jane Ding, Fabrizio Luppi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 11, 2024
Refining the definition of miliary/disseminated tuberculosis in CanadaYiming Huang, Richard Long, Giovanni Ferrara, et al.
Scientific Reports|June 11, 2024
Factors associated with phenotypes of dyspnea in post-COVID-19 condition: a cross-sectional studyMaeve P Smith, Heather Sharpe, Ronald W Damant, et al.
Frontiers in Medicine|March 2, 2026
Interstitial lung abnormalities: to treat or not to treat? The hamlet dilemmaUmberto Zanini, Giovanni Franco, Chiara Pirotta, et al.
Respiratory Medicine|February 14, 2006
Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugsLuigi Ruffo Codecasa, Giovanni Ferrara, Maurizio Ferrarese, et al.
The American Journal of Medicine|August 3, 2025
Decoding objective cough features in progressive pulmonary fibrosis: a 6-month feasibility studyMicheal D Feist, Yiming Huang, Meena Kalluri, et al.
BMJ Open Respiratory Research|September 2, 2024
Understanding facilitators and barriers to oxygen therapy for patients with interstitial lung diseaseHeather Sharpe, Samira D Rowland, Charlotte Pooler, et al.
Frontiers in Medicine|November 24, 2022
A case series of dermatomyositis following SARS-CoV-2 vaccinationAiriss R Chan, Jan Willem Cohen Tervaert, Desiree Redmond, et al.
The Lancet. Respiratory Medicine|February 8, 2014
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trialAliaksandr Skrahin, Raija K Ahmed, Giovanni Ferrara, et al.
Pageof 11